Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies
| Autor: | David Bello, Aidan Raney |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Chagas Cardiomyopathy
medicine.medical_specialty Sarcoidosis Cardiomyopathy Myocardial Ischemia Sensitivity and Specificity Right ventricular cardiomyopathy Coronary artery disease Internal medicine medicine Humans Cardiomyopathy Restrictive Ischemic cardiomyopathy business.industry Hypertrophic cardiomyopathy Restrictive cardiomyopathy Dilated cardiomyopathy General Medicine Amyloidosis Cardiomyopathy Hypertrophic medicine.disease Magnetic Resonance Imaging Myocarditis Heart failure Cardiology Fabry Disease Hemochromatosis Cardiology and Cardiovascular Medicine business Cardiomyopathies |
| Zdroj: | Heart failure clinics. 2(2) |
| ISSN: | 1551-7136 |
| Popis: | Cardiomyopathies are defined as diseases of the myocardium associated with cardiac dysfunction. Patients who have cardiomyopathy are classified into ischemic cardiomyopathy (ICM) or nonischemic cardiomyopathy (NICM) categories based on the presence or absence, respectively, of coronary artery disease (CAD). The World Health Organization/ International Society and Federation of Cardiology (WHO/ISFC) task force classifies NICM as dilated cardiomyopathy, hypertrophic cardiomyopathy (HCM) (obstructive and nonobstructive), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC) [1]. The ‘‘unclassified’’ cardiomyopathies do not readily fit into any single group, and ‘‘specific’’ cardiomyopathies are associated with specific cardiac or systemic disorders. (eg, hypertensive cardiomyopathy) (Table 1). Patients who have cardiomyopathy and associated heart failure symptoms represent an important epidemiologic problem. Approximately 5 million patients in the United States have heart failure, and over 550,000 patients are diagnosed with heart failure for the first time each year [2]. From 1990 to 1999, the annual number of hospitalizations increased from 810,000 to over 1 million for heart failure as the primary diagnosis and from 2.4 to 3.6 million |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|